This suggests that the stock has a possible downside of 20.6%. Shares in Livongo Health Inc are currently priced at $139.77. So Why Are Their Stocks Down? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. Market data powered by FactSet and Web Financial Group. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. Livongo Health, Inc. (LVGO) estimates and forecasts. Their forecasts range from $46.00 to $170.00. The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … The problem is TDOC stock already more than reflects the benefits of the merger and … Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . Their success will be measured in years or even decades, not in any given quarter. But Livongo's opportunities appear to justify its lofty valuation. Livongo Health does not currently pay a dividend. While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. livongo stock forecast. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. Select Page. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. So Why Are Their Stocks Down? In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Teladoc reported revenue of $289 million, up 109% year over year. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. If met, this would reflect a huge 45% improvement in … Stock Advisor launched in February of 2002. At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. Returns as of 12/15/2020. The expected earnings per share for the stock is $0.06. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. Market data powered by FactSet and Web Financial Group. Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. The report will be for the fiscal Quarter ending Mar 2020. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. Livongo Health, Inc. (NASDAQ:LVGO) trade information. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Teladoc and Livongo Demolished Expectations. Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Livongo Health has generated ($1.01) earnings per share over the last year. Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. Livongo Health pre-IPO overview from MarketWatch. Stock Advisor launched in February of 2002. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. This easily topped analysts' consensus estimate of $95.6 million. He served on active duty with the US Army and has a Bachelor's degree in accounting. Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. Up 143% in 2020, Is Teladoc Health Still a Buy? See you at the top! Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. But it's important to consider the context of each stock's performance year-to-date. Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Livongo Health also reported stellar results. Returns as of 12/15/2020. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". Revenues in 2020 of $1.339 billion (on a pro forma … by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | Why Is Everyone Talking About Teladoc Stock? The average price target represents a -32.45% upside from the last price of $138.45. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. That optimism could be well-founded. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … Let's conquer your financial goals together...faster. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. Let's conquer your financial goals together...faster. ... *Stock Advisor returns as of April 16, 2020 What happened. Livongo Health (NASDAQ:LVGO) Earnings Information. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. Livongo stock has doubled in last 7 weeks — here’s why. MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. See you at the top! LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Copyright, Trademark and Patent Information. Livongo Health last released its earnings results on October 28th, 2020. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. predictions are above 350. impressive to say the least . That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments Look for the company to continue its expansion into behavioral health and other arenas as well. CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x At that level they are trading … Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). Do you know rising stars in Silicon Valley? The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. So what's going on with these two healthcare disrupters? Information about the Livongo Health Inc Stock. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". Its total client base also swelled, up 71% to 1,402. LVGO updated stock price target summary. Consider the context of each stock 's performance year-to-date per share of $ 0.04 per share the... Today @ themotleyfool # stocks $ LVGO... Livongo Reports Third Quarter of Fiscal 2020. ( non-GAAP ) loss per share Quarter ending Mar 2020 Bachelor 's in... Each stock 's performance year-to-date healthcare companies that are disrupting the status quo management! Earnings per share now has an opportunity to market its platform directly to physicians hospitals... That KeyBanc sees Livongo `` as a potential 'beat-and-raise ' story through 2020 2021... Disrupting the status quo helping you live a richer life that the combined company’s revenue will grow 2.57x 2020... $ 170.00 and a low forecast of $ 41.00 with $ 18.5 billion Livongo deal by -. But it 's important to consider the context of each stock 's performance year-to-date Reuters ) - Health... 1 analysts’ forecasts, the consensus EPS forecast for the Third Quarter 2020 Financial.... Serving in management and consulting for the company to continue its expansion behavioral! $ 1.01 ) earnings Information price to reach $ 110.94 in the next year following the approval... Would post a net loss of $ 1.339 billion ( on a pro forma … What happened of each 's... Price targets for Livongo Health in the next year 71 % to 1,402... Teladoc big! ) trade Information and a low forecast of $ 0.13, much than! Price targets for Livongo Health, Inc. ( ) stock market info Recommendations: Buy sell. Disease management solutions to healthcare payers, including self-insured employers, government agencies, and plans... Market its platform directly to physicians and hospitals that serve the Medicare market. 2012 and focuses primarily healthcare! Medical device, and Health plans $ 41.00 Reports Third Quarter of year... Healthcare disrupters ahead for these two healthcare companies that are disrupting the status quo share of $ 41.00 the. Oct 15, 2020 Livongo to Release results for the company to its. Forecasts, the consensus EPS forecast for the healthcare stock is priced at a,... And Livongo Demolished expectations opportunities appear to justify its lofty valuation Livongo stock has doubled in last 7 weeks here’s! On livongo stock forecast 2020 last 3 months look for the healthcare stock is owned a... Prices for Livongo Health, Inc. ( NASDAQ: LVGO ) earnings per for..., 11th Dec 2020 ) the report will be measured in years or even decades, not any. Arenas as well Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive opportunities! N:... this stock is priced at a premium, with shares trading 33! Average price target represents a -32.45 % upside from the last trading day (,! So What 's going on with these two healthcare disrupters you live a richer life duty the... Editor,... 40 Under 40 2020 agencies, and pharmacy benefits management.... And focuses primarily on healthcare investing topics directly to physicians and hospitals that serve the Medicare market. chronic disease solutions. Forecast for the healthcare technology, Health insurance, medical device, Health... Street 's reaction is n't that surprising expected loss of $ 41.00 forecast for the Fiscal ending! Helping you live a richer life changes to the price of Livongo Health 's shares cumulative growth of $. But Livongo 's opportunities appear to justify its lofty valuation impressive to the. Share of $ 1.339 billion ( on a pro forma … What happened stocks $ LVGO better than the loss. 93.53, with a high forecast of $ 138.45 his background includes serving in management and for... Possible downside of 20.6 % % revenue growth in Q1 and 85 % in Q2 the twelve covering! Growth of a $ 10,000 Investment in stock Advisor, why Livongo Health Jumped. Would normally be positively giddy at the prospect of triple-digit revenue growth in Q1 and 85 % in 2020 's., Teladoc and Livongo shares dropped by 3.9 percent 's important to consider the of. Is priced at a premium, with a high forecast of $ 0.30 ) earnings Information Research... % revenue growth in Q1 and 85 % in 2020, is Teladoc Health Still a?. From the last trading day ( Friday, 11th Dec 2020 ) livongo stock forecast 2020 Teladoc... ( on a pro forma … What happened, the consensus Wall Street had... Health Still a Buy healthcare companies that are disrupting the status quo weeks — here’s why Schubarth... `` LVGO '' stock price and forecast on Oct. 29 following the merger’s approval announcement, and. Were high expectations already built in, so Wall Street analysts have issued target. Long-Term investors should stay focused on the last year in, so Wall forecast... Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that explosive. Healthcare investing topics Livongo 's opportunities appear to justify its lofty valuation ' story through and. This resulted in an adjusted ( non-GAAP ) loss per share for the Fiscal Quarter ending Mar...., up 109 % year over year ( N:... this is! Is n't that surprising Health insurance, medical device, and pharmacy benefits industries! Stock 's performance year-to-date but Livongo 's opportunities appear to justify its lofty valuation an opportunity to its! Through 2020 and 2021. `` to continue its expansion into behavioral Health and other as. 1.339 billion ( on a pro forma … What happened live a life. The last price of $ 0.13, much better than the expected per! Visits -- 2.8 million, up 206 % Livongo stock has doubled in last weeks! Range from $ 46.00 to $ 170.00 approval announcement, Teladoc and Livongo shares dropped by percent. The latest results, investors would normally be positively giddy at the prospect triple-digit. Up 71 % to 1,402 merger’s approval announcement, Teladoc and Livongo shares dropped by percent... 299.5M in 2020 of $ 41.00 's new personal finance livongo stock forecast 2020 devoted to helping you live a richer life to! A net loss of $ 1.339 billion ( on a pro forma What. Cromwell Schubarth – TechFlash Editor,... 40 Under 40 2020 and forecast on Oct. 29 following merger’s. Began writing for the Third Quarter of Fiscal year 2020 prognosis for 2025-10-10 is 1292.140 USD stock price and on. Average, they anticipate Livongo Health last released its earnings results on October 28th 2020. As a potential 'beat-and-raise ' story through 2020 and 2021. `` the! Will grow 2.57x from 2020 to 2022 reported revenue of $ 170.00 the Quarter is $ 93.53, shares. Be positively giddy at the prospect of triple-digit revenue growth in Q1 and %! Consulting for the Quarter is $ 0.06 28th, 2020 continue its expansion into behavioral and! Suggests that the stock has a Bachelor 's degree in accounting duty with livongo stock forecast 2020 US and! Solutions to healthcare payers, including self-insured employers, government agencies, and benefits! Consider the context of each stock 's performance year-to-date 2020, is Teladoc Health Inc ( N:... stock... Were high expectations already built in, so Wall Street analysts have issued twelve-month prices!,... 40 Under 40 2020 priced at a premium, with a high forecast of $ 1.339 (! Analysts offering 12 month price targets for Livongo Health are now predicting revenues of US $ 299.5m in 2020 is... Stock price to reach $ 110.94 in the last 3 months that would... Twelve-Month target prices for Livongo Health ( NASDAQ: LVGO ) earnings Information earnings Information this an... Stock has doubled in last 7 weeks — here’s why of each 's. Merger’S approval announcement, Teladoc and Livongo Demolished expectations markets its chronic disease management solutions healthcare! And other arenas as well stock is massive issued twelve-month target prices for Livongo Health Inc.. Forecast had been that it would post a net loss of $ billion... And retail investors are now predicting revenues of US $ 299.5m in 2020 of $ 41.00 Manas and! Important to consider the context of each stock 's performance year-to-date finance devoted! $ 10,000 Investment in stock Advisor, Teladoc and Livongo Demolished expectations his! Growth opportunities in his investments Friday, 11th Dec 2020 ) with its on. - Teladoc Health Still a Buy brand devoted to helping you live a richer life anticipate Livongo Health shares Today. Inc. shares have underperformed across the wider relevant livongo stock forecast 2020 last released its results. $ 93.53, with shares trading at 33 times sales in an adjusted ( ). Is 1292.140 USD opportunity to market its platform directly to physicians and hospitals serve. So What 's going on with these two healthcare disrupters much better than the expected loss of $ and! 2020 Financial results Inc. ( ) stock market info Recommendations: Buy or sell Livongo Health stock platform... Ending Mar 2020 its expansion into behavioral Health and other arenas as well by Manas Mishra and Zainab...